Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

4.940
+0.0701.44%
Volume:4.23M
Turnover:20.83M
Market Cap:31.04B
PE:8.78
High:4.960
Open:4.880
Low:4.860
Close:4.870
Loading ...

Dong-E-E-Jiao to See Boost in 2024 Profit

MT Newswires Live
·
20 Jan

BRIEF-China Resources Pharmaceutical Sees FY Net Profit Attributable Of Dong-E-E-Jiao RMB1,500 Million To RMB1,600 Million

Reuters
·
17 Jan

China Resources Pharmaceutical Sees Net Profit Attributable of Dong-E-E-Jiao for Year RMB1,500 Mln to RMB1,600 Mln

THOMSON REUTERS
·
17 Jan

China Resources Pharmaceutical Sells 1.6 Billion Yuan of Three-Year Corporate Bonds

MT Newswires Live
·
15 Jan

China Resources Pharmaceutical Group to Renew Cooperation Agreements

MT Newswires Live
·
03 Jan

Does China Resources Pharmaceutical Group (HKG:3320) Have A Healthy Balance Sheet?

Simply Wall St.
·
19 Dec 2024

China Resources Pharmaceutical - Unit Acquired Additional 6.4 Mln Shares of Dong-E-E-Jiao From 8 Nov-18 Dec

THOMSON REUTERS
·
18 Dec 2024

China Resources Pharmaceutical - Unit Acquired Additional 5.0 Mln Shares of China Resources Boya Bio-Pharmaceutical From 8 Nov-18 Dec

THOMSON REUTERS
·
18 Dec 2024

BRIEF-China Resources Pharmaceutical Says Unit Issued Perpetual Bonds In PRC

Reuters
·
11 Dec 2024

China Resources Pharmaceutical - 2024 Perpetual Bonds to Be Issued in Aggregate Principal Amount of Not More Than RMB3 Bln

THOMSON REUTERS
·
11 Dec 2024

China Resources Pharmaceutical Unit Registers 15 Billion Yuan Asset-Back Debt Issuance

MT Newswires Live
·
05 Dec 2024

BRIEF-China Resources Pharmaceutical Announces Registration Of Asset-Backed Notes

Reuters
·
05 Dec 2024

China Resources Pharmaceutical Group Ltd - Registration of Asset-Backed Notes by National Association of Financial Market Institutional Investors

THOMSON REUTERS
·
04 Dec 2024

China Resources Pharmaceutical - China Resources Pharmaceutical Commercial May Issue Asset-Backed Notes in Aggregate Amount of RMB15 Bln

THOMSON REUTERS
·
04 Dec 2024

BRIEF-Pfizer Investment to Jointly Commercialize Cancer Drugs with China Resources Pharmaceutical

Reuters
·
26 Nov 2024

Pfizer Investment: Signs Strategic Partnership With China Resources Pharmaceutical Commercial Group to Jointly Commercialize Four Key Drugs for Breast and Lung Cancer

THOMSON REUTERS
·
26 Nov 2024

BRIEF-China Resources Pharmaceutical CR Sanjiu To Sell 51% Interest In CR Shenghuo For RMB1.79 Bln

Reuters
·
21 Nov 2024

China Resources Pharmaceutical Group Ltd - Cr Sanjiu to Sell 51% Interest in Cr Shenghuo for RMB1,791 Mln

THOMSON REUTERS
·
21 Nov 2024

China Resources Pharmaceutical Group (HKG:3320) shareholders have earned a 20% CAGR over the last three years

Simply Wall St.
·
13 Nov 2024

KPC Pharmaceuticals's Nine-Month Profit Rises Slightly

MT Newswires Live
·
28 Oct 2024